Methods The series comprises MS patients, seen in the Demyelinating Disease Unit of a
tertiary hospital, who fulfilled the following criteria: clinically defined MS (relapsing-remitting …

Background More research is needed to understand the contribution of comorbidities to MS
symptomatology. Objectives To examine the dose–response relationship between the …

Background There is limited knowledge regarding how depressive symptoms and a cluster
of specific mood symptoms in people with multiple sclerosis (MS) vary over time and how …

Background The lifetime prevalence of depression in people with multiple sclerosis (MS)
is∼ 50% and international studies have reported untreated and under-treated depressive …

The aim of this study was to evaluate the frequency of psychiatric disorders, particularly
mood disorders and anxiety in an outpatient sample of patients with multiple sclerosis in …

Introduction. Although depression is the most frequent psychiatric disorder accompanying
multiple sclerosis (MS) patients, only few studies have examined the impact of depression …

Background Comorbidities occur frequently in persons with multiple sclerosis (MS). The aim
of the present study was to determine the prevalence of the most common comorbidities in …

Background and Objectives Psychiatric morbidity is common after a multiple sclerosis (MS)
diagnosis. However, little is known about psychiatric comorbidity during the prodromal …

A high prevalence of major mood disorders in multiple sclerosis (MS) patients has been
reported. In this study, we investigated the frequency of previous or present major mood …

Objective Prevalence rates of depression and anxiety in patients with Multiple Sclerosis
(MS) vary widely across studies. Aim of this systematic review and meta-analysis was to a) …